NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

My takeaway purely from reading rogers (thank you rogers for taking the time) posts regarding ASM is:

1) Linda suggested targeted OS event s were reached but the trial will continue as that event number is minimal or a floor but not the trigger for data lock. In this sense, she or the company has been consistent as their previous use of the “minimal” preceding the targeted OS event number. So no contradictory here, which I buy it. Keyword: the trial is continuing and will be until it is enough judged by Linda or based on certain conditions unknown at this time;

2) Manuscript was submitted in last fall. Based on the strictness of not hinting any more detail, the writing must be of substantial significance. Dependent on unknown situations, it will be published any day after today. Because there was no vote on share increase in this ASM, it becomes more likely that the company is indeed waiting for the publication before that vote;

3) Black realized how badly the company has been attacked, and is still collecting data, weighing on the next step. If I were him, I would launch actions if any after at least the publication of blinded data, or mostly preferably after unblinded data are made public.

4) All the above suggest Linda will not say anything substantial in the coming conference, but I hope I am totally wrong.

BTW, please don't launch any new trial before final data are known because we don't like one more substantial dilution!!!

BTW2: if I may guess a price move next week, I would say there will be a floor at 0.23, of course not a trigger for capitulation or upside breaking out either. Or It may surprise anybody by resuming the steady climbing after a short time hiccup depending on if there are significant demands for shares by institutions. As long as there are substantial institutional interests, share price will only climb.